About the Company
We do not have any company description for MiNK Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 14, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1 ...
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
Peer-Reviewed Review of iNKT Cell Therapy: A Frontiers in Immunology featured MiNK’s platform, highlighting iNKT cells’ can remodel the tumor microenvironment and overcome therapeutic resistance, ...
MiNK Therapeutics Reports Q2 2025 Milestones and Financials
Mink Therapeutics, Inc. ( ($INKT) ) has released its Q2 earnings. Here is a breakdown of the information Mink Therapeutics, Inc. presented to its ...
MiNK Therapeutics, Inc. to Announce Fourth Quarter and Year ... - Nasdaq
MiNK Therapeutics, Inc. has announced that it will release its financial results for the fourth quarter and year-end 2024 on March 18, 2025, prior to market opening.
MiNK Therapeutics, Inc. (INKT) Upgraded to Buy: What Does It ... - Nasdaq
MiNK Therapeutics, Inc. (INKT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment ...
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of ...
INKT | MiNK Therapeutics Inc. Profile | MarketWatch
MiNK Therapeutics Inc. 149 5th Avenue Suite 500 New York, New York 10010 Phone1 212 994-8250 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2024 RevenueN/A Net Income-$22.46M ...
MiNK Therapeutics, Inc. (INKT) Q4 2022 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2022 Results Conference Call March 21, 2023 8:30 AM ETCompany ParticipantsZack Armen - Head of Investor Relations ...
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2024 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ: INKT) Q3 2024 Earnings Call Transcript November 14, 2024 Emily Bodnar – H.C. Wainwright: Operator: Thank you for standing by.
Similar Companies
Loading the latest forecasts...